<DOC>
	<DOCNO>NCT00003587</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Randomized phase II trial study effectiveness two different combination chemotherapy regimens treat patient stage IIIB stage IV non-small cell lung cancer</brief_summary>
	<brief_title>S9806 : Combination Chemotherapy Treating Patients With Stage IIIB Stage IV Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I. Assess survival failure free survival patient advance primary non-small cell lung cancer treat carboplatin gemcitabine follow paclitaxel OR cisplatin vinorelbine follow docetaxel . II . Evaluate response ( confirmed plus unconfirmed ) toxicity associate two regimen patient . OUTLINE : This randomize study . Patients randomize one two treatment arm . Arm I : Patients receive carboplatin IV 30 minute day 1 follow gemcitabine IV 30 minute day 1 8 . Treatment repeat every 21 day 3 course . Following 3 course carboplatin gemcitabine , patient receive paclitaxel IV 3 hour day 1 every 21 day 3 course . Arm II : Patients receive cisplatin IV 30-60 minute day 1 follow vinorelbine IV 6-10 minute day 1 8 . Treatment repeat every 21 day 3 course . Following 3 course cisplatin vinorelbine , patient receive docetaxel IV 1 hour day 1 every 21 day 3 course . Patients receive treatment evidence disease progression . Patients follow every 2 month first year , every 6 month year 2 3 , annually thereafter . PROJECTED ACCRUAL : A total 160 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm newly diagnose stage IIIB IV advance primary nonsmall cell lung cancer ( adenocarcinoma , large cell carcinoma , squamous cell carcinoma , unspecified ) recurrent nonsmall cell lung cancer previous surgery and/or radiotherapy Stage IIIB : T4 lesion due malignant pleural effusion , OR multiple lesion single lobe contain T3 T4 primary , OR lesions multiple lobes ipsilateral lung one lesion T3 T4 Any N M0 Stage IV : Any T , Any N , M1 Measurable evaluable disease Measurable evaluable disease must outside prior radiotherapy port prior surgical resection area No brain metastases No bronchoalveolar carcinoma stage IIIB tumor involve superior sulcus ( pancoast tumor ) PATIENT CHARACTERISTICS : Age : 18 Performance status : SWOG 01 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Creatinine great 2 time upper limit normal AND Creatinine clearance least 50 mL/min Other : No prior malignancy past 5 year except adequately treat basal cell squamous cell skin cancer , carcinoma situ cervix , adequately treated stage I II cancer patient currently complete remission Not pregnant nursing Effective contraception require fertile patient PRIOR CONCURRENT THERAPY : Biologic therapy : No prior biologic therapy nonsmall cell lung cancer No concurrent biologic therapy measurable evaluable lesion Chemotherapy : No prior systemic chemotherapy nonsmall cell lung cancer Endocrine therapy : No concurrent hormonal therapy measurable evaluable lesion Radiotherapy : At least 3 week since prior radiotherapy recover No concurrent radiotherapy measurable lesion Palliative radiation small field nonmeasurable site disease ( painful bony metastasis ) allow Surgery : At least 3 week since surgery ( thoracic major surgery ) recover</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>squamous cell lung cancer</keyword>
	<keyword>large cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>adenocarcinoma lung</keyword>
</DOC>